Thought Leadership
Blog | January 02, 2012
Read more
NDCA denies Daubert motion for Defendant's damages expert
Fish & Richardson
Article | December 02, 2011
Read more
Orange Book Listing Opportunities for Drug-Device Combinations
BNA Pharmaceutical Law & Industry Report
Blog | December 01, 2011
WD TN Grants New Trial on Damages after Remand Because the Reasonable Royalty Rate in the Original Verdict Was Based on the Now-Defunct 25%
Fish & Richardson
Read more
Article | November 08, 2011
Read more
Inspiration or infringement?: Examining the Janine Gordon v. Ryan McGinley Photography Case
Intellectual Property Magazine
Article | October 21, 2011
Read more
Is It Time for FDA to Revise Its Orange Book Rules to Deal with Skinny Labeled Generic Drugs?
FDLI's Food and Drug Policy Forum
Blog | October 19, 2011
EDTX Finds Duty to Mark Gift Cards (Alexsam v. Pier 1 Imports)
Fish & Richardson
Read more
Blog | September 30, 2011
EDTX Awards Supplemental Damages (Pre- and Post-Verdict)
Fish & Richardson
Read more
Blog | August 12, 2011
EDTX Issues Pretrial Rulings on Reasonable Royalty and Lost Profits Damages
Fish & Richardson
Read more
Article | August 10, 2011
Read more
New FDA Draft Guidance Sheds Light On Regulation of 'Mobile Medical Apps' and Other Software
BNA Medical Devices Law & Industry Report
Blog | August 08, 2011
NDTX Strikes One License and Allows Another; Finds Fault in Expert's Use of Entire Market Value Rule
Fish & Richardson
Read more
Blog | July 20, 2011
Competitor Case: EDVA Guts Price Erosion and Lost Sales Case and Finds Lump Sum Reasonable Royalty Theory Flawed
Fish & Richardson
Read more